Catalent touts customer confidence ahead of Novo deal, but misses revenue estimates

The FDA on Fri­day un­veiled new de­tails around a rare dis­ease pi­lot pro­gram that seeks to in­crease rapid, ad-hoc com­mu­ni­ca­tions be­tween six spon­sors work­ing on

A ma­jor­i­ty of for­mer and cur­rent FDA ad­vi­so­ry com­mit­tee mem­bers sur­veyed in Ju­ly sup­port­ed re­mote par­tic­i­pa­tion in meet­ings and bet­ter com­mu­ni­ca­tion, as the FDA con­sid­ers